Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-002968-10Phase 2Terminated
Phase 2, randomised, double-blind trial in cancer anorexia-cachexia syndrome (CACS) comparing dronabinol with placebo (2 arms). Primary endpoint: weight change. Started Oct 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-002968-10.